95493-97-3

Upstream product

• 52222-45-4 2-(benzylthio)-5-nitrosopyrimidine-4,6-diamine 
• 84890-62-0 2-(benzylthio)pyrimidine-4,6-diamine 
• 100-39-0 benzyl bromide 

Downstream Products

• 1099593-17-5 4-amino-2-(benzylthio)-5,8-dihydropteridine-6,7-dione 
• 1260177-39-6 (2R,3R,4S,5R)-2-(7-amino-5-(benzylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol 
• 1260177-44-3 5-(benzylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine 
• 849943-03-9 methyl 4-amino-2-(benzylthio)-7-oxo-7,8-dihydropteridine-6-carboxylate 

Relevant academic research and scientific papers

Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors

Inhibitors of adenosine deaminase (ADA, EC 3.5.4.4) are potential therapeutic agents for the treatment of various health disorders. Several highly potent inhibitors were previously identified, yet they exhibit unacceptable toxicities. We performed a SAR s

Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria

A successful scaffold-hopping approach gave a novel series of inhibitors of bacterial glutamate racemase (MurI). Early SAR studies of the 8-benzyl pteridine-6,7-diones led to compounds with micromolar enzyme potency and antibacterial activity.